XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Assets    
Loans receivable, net of deferred origination and other fees $ 57,961,155 $ 65,405,731
Interest and other fees receivable on loans 1,578,806 1,521,033
Cash 186,435 178,012
Cash – restricted 13,847 23,750
Other assets 128,431 62,080
Right-of-use asset – operating lease, net 114,429 154,039
Deferred financing costs, net 5,775 16,171
Total assets 59,988,878 67,360,816
Liabilities:    
Line of credit 9,049,624 16,427,874
Senior secured notes (net of deferred financing costs of $40,672 and $96,985, respectively) 5,959,328 5,903,015
Accounts payable and accrued expenses 171,558 232,236
Operating lease liability 126,051 167,119
Loan holdback 50,000 50,000
Dividends payable 1,315,445 1,315,445
Total liabilities 16,672,006 24,095,689
Commitments and contingencies  
Stockholders’ equity:    
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 outstanding 11,757 11,757
Additional paid-in capital 45,571,739 45,561,941
Less: Treasury shares, at cost – 318,407 shares (1,070,406) (1,070,406)
Accumulated deficit (1,196,218) (1,238,165)
Total stockholders’ equity 43,316,872 43,265,127
Total liabilities and stockholders’ equity $ 59,988,878 $ 67,360,816